Our R&D Approach

Our research mission is simple: innovations that improve the quality of life of people everywhere. That motivation keeps us at the forefront of the Healthcare, Life Science and Electronics industries.

Healthcare R&D

Our research scientists are working tirelessly to develop groundbreaking medicines and technologies to treat everything from cancer and multiple sclerosis to infertility. Wherever there is a medical need, our highly experienced research and development team hopes to meet it. Learn more

Life Science R&D

R&D focus: Reimagining new ways to meet the needs of our customers

Innovation is at the core of the value that we deliver to our customers. Our Life Science scientists and engineers tirelessly work to develop novel approaches to new and age-old challenges.We show our commitment to innovation through our financial investments as well. Every year, we invest around €400 million in R&D, supporting new innovations designed to meet our customers' most unmet needs – from antibodies to water purification systems. Innovation is visible when new products hit the shelves and when new services emerge. 

The ability to innovate is the core of our culture across all three of our businesses; Science & Lab Solutions, Process Solutions and Life Science Services. Learn more

Electronics R&D

R&D focus: Keeping the world’s Electronics on the cutting edge

Our Electronics business is an innovation leader, constantly producing new technologies and new markets for our customers, often through partnerships across industries. We have come up with groundbreaking liquid crystal displays and windows, effect pigments for coatings and color cosmetics and high-tech materials for use in integrated circuits. Learn more

Related News

View All News
  1. Press Releases

    MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies ...

    Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies

    2025/10/28

  2. Press Releases

    Global Hackathon by Merck KGaA, Darmstadt, Germany, and Boltz Sets New Benchmark ...

    Our global hackathon on protein folding has set a new benchmark for open-source AI-driven innovation in drug development.

    2025/10/27

  3. Press Releases

    EMD Serono Announces Agreement with U.S. Government to Expand Access to IVF ...

    EMD Serono and President Donald J. Trump’s administration today announced an agreement to expand access to the company’s IVF portfolio.

    2025/10/16